1 – 20 of 59
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
2024) In Oncogene(
- Contribution to journal › Article
- 2021
-
Mark
Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential
2021) In Oncogene(
- Contribution to journal › Scientific review
- 2020
-
Mark
FRMD6 has tumor suppressor functions in prostate cancer
2020) In Oncogene(
- Contribution to journal › Article
- 2019
-
Mark
The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
(
- Contribution to journal › Article
-
Mark
Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality
(
- Contribution to journal › Article
- 2018
-
Mark
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
(
- Contribution to journal › Article
- 2017
-
Mark
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis
(
- Contribution to journal › Article
- 2016
-
Mark
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Targeting of nucleotide-binding proteins by HAMLET-a conserved tumor cell death mechanism.
2015) In Oncogene(
- Contribution to journal › Article
-
Mark
The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.
(
- Contribution to journal › Article
-
Mark
TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.
(
- Contribution to journal › Article
- 2014
-
Mark
The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.
(
- Contribution to journal › Article
- 2013
-
Mark
Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.
(
- Contribution to journal › Article
-
Mark
MiR-155-mediated loss of C/EBP beta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
(
- Contribution to journal › Article
-
Mark
The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ER alpha, and is an independent prognostic factor in node-negative breast cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis
(
- Contribution to journal › Article
-
Mark
Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.
(
- Contribution to journal › Article